— Know what they know.
Not Investment Advice
Also trades as: 0R0H.L (LSE) · $vol 3M · TN8.DE (XETRA) · $vol 0M · TMO.TO (TSX) · $vol 0M · TMO.NE (NEO) · $vol 0M

TMO NYSE

Thermo Fisher Scientific Inc.
1W: +0.8% 1M: +1.4% 3M: +18.8% YTD: +15.6% 1Y: +19.8% 3Y: +46.8% 5Y: +17.8%
$693.02
+8.13 (+1.19%)
After Hours: $695.49 (+2.47, +0.36%)
Weekly Expected Move ±4.1%
$619 $647 $674 $701 $729
NYSE · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Buy · Power 70 · $253.2B mcap · 369M float · 0.594% daily turnover · Short 45% of daily vol
Credit Risk of going bust: lower than 79% of companies Debt: 14.0% of company value Bonds: $454.1M held by 353 funds, 52 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $7.50 (down 99%), Thermo Fisher Scientific Inc. would be worth roughly what it owes.
Total debt $41.37B against a stock market value of $253.24B.
Distance to default 9.42 (Merton model): prices to 2026-10-26, balance sheet 2026-09-26, debt counted $21.82B (short-term plus half of long-term), stock volatility 29.2%; Altman Z'' 2.15. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
37.0 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 8.6%  ·  5Y Avg: 9.6%
Cost Advantage
30
Intangibles
31
Switching Cost
12
Network Effect
50
Scale ★
85
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TMO has No discernible competitive edge (37.0/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. ROIC of 8.6% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$730
Low
$767
Avg Target
$800
High
Based on 5 analysts since Oct 21, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 36Hold: 7Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$741.85
Analysts13
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-22 UBS Douglas Schenkel $730 $800 +70 +16.5% $686.55
2026-10-22 RBC Capital Dan Leonard $740 $730 -10 +6.2% $687.49
2026-10-22 Stifel Nicolaus — $650 $775 +125 +11.7% $694.02
2026-10-22 Robert W. Baird — $639 $756 +117 +8.9% $694.02
2026-10-22 Barclays Luke Sergott $750 $775 +25 +11.7% $694.02
2026-10-15 RBC Capital — $580 $740 +160 +9.9% $673.20
2026-10-15 Guggenheim — Initiated $740 — +9.9% $673.20
2026-10-12 Morgan Stanley — $650 $730 +80 +10.7% $659.60
2026-10-07 Barclays Luke Sergott $650 $750 +100 +14.2% $656.58
2026-09-25 Deutsche Bank — $630 $720 +90 +8.2% $665.25
2026-09-08 UBS — $615 $730 +115 +21.1% $603.02
2026-09-03 CLSA Michael Luo Initiated $748 — +22.9% $608.54
2026-08-05 Stifel Nicolaus — $600 $650 +50 +15.1% $564.75
2026-07-27 Piper Sandler — $510 $600 +90 +5.6% $568.26
2026-07-24 Morgan Stanley — $620 $650 +30 +14.4% $568.26
2026-07-24 RBC Capital Dan Leonard $490 $580 +90 +3.4% $561.09
2026-07-23 Jefferies Tycho Peterson Initiated $630 — +10.0% $572.60
2026-07-06 Evercore ISI — $650 $570 -80 +11.5% $511.31
2026-06-26 Bernstein — Initiated $520 — +2.8% $505.75
2026-06-11 Piper Sandler — Initiated $510 — +5.8% $482.04
2026-06-03 HSBC Sidharth Sahoo $670 $540 -130 +12.0% $482.08
2026-05-14 RBC Capital — $561 $490 -71 +9.3% $448.21
2026-04-27 Morgan Stanley Kallum Titchmarsh $656 $620 -36 +31.3% $472.23
2026-04-24 Stifel Nicolaus Daniel Arias $700 $600 -100 +28.4% $467.47
2026-04-24 Robert W. Baird Catherine Ramsey Schulte $653 $639 -14 +36.9% $466.70
2026-01-30 UBS — $590 $615 +25 +6.1% $579.86
2026-01-30 Wells Fargo — $675 $683 +8 +17.7% $580.09
2026-01-30 Robert W. Baird — $622 $653 +31 +12.0% $583.12
2026-01-30 Barclays — $625 $650 +25 +9.8% $592.16
2026-01-09 Stifel Nicolaus Daniel Arias $680 $700 +20 +15.4% $606.50
2026-01-05 Evercore ISI Vijay Kumar $585 $650 +65 +7.3% $605.83
2025-12-15 Wells Fargo — $505 $675 +170 +18.0% $571.99
2025-12-09 Goldman Sachs Evie Koslosky $610 $685 +75 +20.6% $568.21
2025-12-07 KeyBanc Paul Knight $710 $750 +40 +30.9% $572.77
2025-10-29 Argus Research — $600 $610 +10 +6.9% $570.82
2025-10-28 Morgan Stanley — $678 $656 -22 +16.5% $563.28
2025-10-23 UBS — $460 $590 +130 +3.2% $571.67
2025-10-23 Barclays — $585 $625 +40 +10.2% $567.20
2025-10-22 Leerink Partners — $630 $580 -50 +2.3% $567.20
2025-10-08 Redburn Partners — $580 $575 -5 +7.2% $536.19
2025-10-08 Redburn Partners — Initiated $580 — +7.6% $539.17
2025-10-02 Barclays Luke Sergott $610 $585 -25 +10.2% $530.73
2025-09-02 RBC Capital Conor McNamara $693 $561 -132 +15.1% $487.53
2025-07-08 UBS Dan Leonard Initiated $460 — +7.9% $426.17
2025-04-25 Scotiabank — Initiated $605 — +42.6% $424.24
2025-04-23 Goldman Sachs Matthew Sykes $690 $610 -80 +41.3% $431.64
2025-01-31 RBC Capital Conor McNamara $661 $693 +32 +15.9% $597.75
2025-01-02 Evercore ISI Vijay Kumar $630 $585 -45 +11.9% $522.57
2024-10-24 Robert W. Baird Catherine Schulte $632 $622 -10 +7.9% $576.49
2024-10-23 Barclays Luke Sergott $600 $610 +10 +6.8% $570.92

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 27, 2026
DCF
3
ROE
4
ROA
4
D/E
1
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TMO receives an overall rating of B. Strongest factors: ROE (4/5), ROA (4/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-26 B- B
2026-10-22 B B-
2026-10-01 B- B
2026-09-25 B B-
2026-07-25 C- B
2026-07-23 B C-
2026-07-01 B+ B
2026-05-11 B B+
2026-05-06 B+ B
2026-05-05 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 64 Grade A
Profitability
53
Balance Sheet
52
Earnings Quality
76
Growth
51
Value
43
Momentum
80
Safety
80
Cash Flow
67
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TMO scores highest in Safety (80/100) and lowest in Value (43/100). An overall grade of A places TMO among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.32
Safe Zone
Piotroski F-Score
8/9
✓ ✓ ✓ ✓ ✗ ✓ ✓ ✓ ✓
Beneish M-Score
-2.43
Unlikely Manipulator
Ohlson O-Score
-9.10
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 62.9/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.32x
Accruals: -2.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TMO scores 3.32, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TMO scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TMO's score of -2.43 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TMO's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TMO receives an estimated rating of BBB+ (score: 62.9/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). TMO's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
36.88x
PEG
3.88x
P/S
5.47x
P/B
4.73x
P/FCF
32.97x
P/OCF
26.86x
EV/EBITDA
26.13x
EV/Revenue
6.03x
EV/EBIT
31.89x
EV/FCF
37.62x
Earnings Yield
2.83%
FCF Yield
3.03%
Shareholder Yield
3.06%
Graham Number
$251.82
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 36.9x earnings, TMO commands a growth premium. Graham's intrinsic value formula yields $251.82 per share, 172% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.900
NI / EBT
×
Interest Burden
0.878
EBT / EBIT
×
EBIT Margin
0.189
EBIT / Rev
×
Asset Turnover
0.436
Rev / Assets
×
Equity Multiplier
2.054
Assets / Equity
=
ROE
13.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TMO's ROE of 13.4% is driven by Asset Turnover (0.436), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.90 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
7.63%
Fair P/E
23.76x
Intrinsic Value
$453.67
Price/Value
1.49x
Margin of Safety
-48.79%
Premium
48.79%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with TMO's realized 7.6% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. TMO trades at a 49% premium to its adjusted intrinsic value of $453.67, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 23.8x compares to the current market P/E of 36.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$693.13
Median 1Y
$756.30
5th Pctile
$470.57
95th Pctile
$1213.19
Ann. Volatility
28.7%
Analyst Target
$741.85
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Marc N. Casper
Chairman, President and Chief Executive Officer
$1,785,534 $65,730,211 $79,923,350
Michel Lagarde Operating
Vice President and Chief Operating Officer
$1,166,433 $3,572,991 $8,907,174
Gianluca Pettiti
Executive Vice President
$1,031,918 $3,293,754 $8,080,467
Stephen Williamson Financial
ce President and Chief Financial Officer
$1,095,170 $2,456,033 $6,781,012
Frederick Lowery
Executive Vice President
$930,356 $2,623,683 $6,575,821

CEO Pay Ratio

1374:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $79,923,350
Avg Employee Cost (SGA/emp): $58,176
Employees: 125,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
125,000
0.0% YoY
Revenue / Employee
$356,448
Rev: $44,556,000,000
Profit / Employee
$53,896
NI: $6,737,000,000
SGA / Employee
$58,176
Avg labor cost proxy
R&D / Employee
$11,176
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE 20.5% 20.0% 18.8% 17.1% 16.4% 14.5% 13.3% 13.4% 13.2% 13.7% 13.6% 13.0% 13.2% 13.7% 13.4% 13.1% 13.0% 13.5% 13.5% 13.4% 13.39%
ROA 9.4% 9.6% 9.4% 8.6% 7.2% 6.4% 6.2% 6.3% 6.1% 6.3% 6.5% 6.2% 6.5% 6.6% 6.6% 6.5% 6.5% 6.5% 6.5% 6.5% 6.52%
ROIC 12.5% 12.5% 12.3% 12.0% 10.8% 9.3% 9.2% 9.5% 9.5% 9.3% 9.2% 8.6% 9.0% 9.3% 9.4% 8.8% 8.8% 8.1% 8.3% 8.6% 8.56%
ROCE 11.5% 11.4% 11.4% 10.8% 10.7% 9.6% 9.0% 9.2% 9.2% 9.7% 10.1% 9.9% 10.3% 10.0% 9.6% 9.7% 9.1% 8.8% 8.8% 9.0% 8.95%
Gross Margin 46.1% 46.4% 41.8% 40.5% 36.3% 39.1% 39.9% 41.0% 36.3% 40.8% 41.2% 41.0% 39.2% 41.0% 37.3% 41.8% 38.0% 40.7% 41.2% 42.8% 42.78%
Operating Margin 25.0% 24.0% 17.7% 16.5% 17.3% 15.9% 16.7% 18.7% 18.3% 16.6% 16.7% 18.1% 19.9% 17.8% 17.7% 17.5% 18.8% 16.9% 17.4% 18.6% 18.65%
Net Margin 15.5% 18.7% 15.2% 14.0% 13.8% 12.0% 12.7% 16.2% 15.0% 12.8% 14.7% 15.4% 16.1% 14.5% 14.9% 14.5% 16.2% 15.0% 14.5% 14.2% 14.18%
EBITDA Margin 25.3% 29.9% 26.4% 24.5% 25.3% 23.5% 24.4% 28.5% 27.8% 26.9% 28.2% 27.4% 26.9% 25.4% 25.8% 25.5% 26.3% 21.0% 24.2% 20.6% 20.64%
FCF Margin 17.9% 17.6% 15.3% 13.2% 15.4% 12.8% 13.5% 15.1% 16.2% 17.8% 18.8% 18.4% 16.9% 15.7% 14.3% 14.0% 14.1% 14.9% 15.8% 16.0% 16.04%
OCF Margin 24.3% 23.8% 21.2% 18.9% 20.4% 17.5% 17.7% 18.8% 19.6% 21.0% 22.1% 21.5% 20.2% 19.0% 17.5% 17.5% 17.5% 18.3% 19.5% 19.7% 19.69%
ROE 3Y Avg snapshot only 12.78%
ROE 5Y Avg snapshot only 13.52%
ROA 3Y Avg snapshot only 6.23%
ROIC 3Y Avg snapshot only 8.18%
ROIC Economic snapshot only 8.10%
Cash ROA snapshot only 8.16%
Cash ROIC snapshot only 10.35%
CROIC snapshot only 8.43%
NOPAT Margin snapshot only 16.29%
Pretax Margin snapshot only 16.62%
R&D / Revenue snapshot only 2.97%
SGA / Revenue snapshot only 15.94%
SBC / Revenue snapshot only 0.18%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio 34.00 30.45 28.75 28.22 30.86 36.82 35.12 32.83 34.14 36.78 33.88 38.29 31.34 29.02 23.40 26.69 32.53 25.74 27.28 35.36 36.882
P/S Ratio 6.70 5.63 4.99 4.49 4.78 5.06 4.62 4.49 4.78 5.22 4.98 5.54 4.63 4.41 3.57 4.01 4.90 3.91 4.11 5.29 5.469
P/B Ratio 6.44 5.65 5.06 4.56 4.88 5.25 4.59 4.30 4.38 4.88 4.44 4.80 4.00 3.83 3.05 3.44 4.09 3.40 3.61 4.57 4.732
P/FCF 37.41 32.01 32.57 34.04 31.04 39.47 34.32 29.80 29.55 29.36 26.47 30.22 27.32 28.12 24.97 28.69 34.71 26.17 26.01 32.97 32.968
P/OCF 27.52 23.70 23.59 23.75 23.43 28.88 26.12 23.87 24.35 24.86 22.55 25.82 22.91 23.23 20.33 22.92 27.94 21.31 21.12 26.86 26.858
EV/EBITDA 24.62 21.84 20.07 19.12 20.27 23.20 21.79 20.31 20.87 21.89 20.12 22.54 19.23 18.77 16.04 18.31 21.71 19.40 20.31 26.13 26.133
EV/Revenue 7.51 6.37 5.66 5.09 5.39 5.79 5.33 5.16 5.44 5.89 5.60 6.22 5.26 5.07 4.23 4.74 5.59 4.79 4.94 6.03 6.034
EV/EBIT 31.43 28.58 26.72 26.32 28.27 33.59 32.02 29.41 30.02 31.10 27.99 31.06 26.16 25.26 21.45 24.30 28.65 25.01 26.51 31.89 31.890
EV/FCF 41.95 36.23 36.89 38.54 35.02 45.12 39.59 34.25 33.64 33.11 29.80 33.90 31.07 32.32 29.65 33.95 39.60 32.08 31.27 37.62 37.616
Earnings Yield 2.9% 3.3% 3.5% 3.5% 3.2% 2.7% 2.8% 3.0% 2.9% 2.7% 3.0% 2.6% 3.2% 3.4% 4.3% 3.7% 3.1% 3.9% 3.7% 2.8% 2.83%
FCF Yield 2.7% 3.1% 3.1% 2.9% 3.2% 2.5% 2.9% 3.4% 3.4% 3.4% 3.8% 3.3% 3.7% 3.6% 4.0% 3.5% 2.9% 3.8% 3.8% 3.0% 3.03%
PEG Ratio snapshot only 3.876
EV/OCF snapshot only 30.645
EV/Gross Profit snapshot only 14.846
Acquirers Multiple snapshot only 33.557
Shareholder Yield snapshot only 3.06%
Graham Number snapshot only $251.82
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 1.50 1.56 1.65 1.74 1.48 1.27 1.42 1.63 1.75 1.70 1.72 1.63 1.66 1.77 1.93 1.50 1.89 1.53 1.55 1.81 1.808
Quick Ratio 1.12 1.10 1.13 1.22 1.15 0.92 1.02 1.25 1.39 1.33 1.37 1.26 1.29 1.38 1.50 1.11 1.53 1.15 1.18 1.41 1.409
Debt/Equity 0.89 0.81 0.72 0.67 0.82 0.83 0.78 0.78 0.78 0.78 0.75 0.72 0.66 0.69 0.70 0.70 0.76 0.83 0.81 0.76 0.755
Net Debt/Equity 0.78 0.74 0.67 0.60 0.63 0.75 0.71 0.64 0.61 0.62 0.56 0.59 0.55 0.57 0.57 0.63 0.58 0.77 0.73 0.64 0.645
Debt/Assets 0.38 0.36 0.33 0.32 0.37 0.37 0.36 0.36 0.37 0.37 0.36 0.35 0.34 0.35 0.35 0.35 0.37 0.38 0.38 0.36 0.362
Debt/EBITDA 3.04 2.77 2.51 2.48 3.02 3.23 3.20 3.20 3.26 3.11 3.00 3.02 2.79 2.95 3.09 3.15 3.56 3.87 3.78 3.78 3.784
Net Debt/EBITDA 2.66 2.54 2.35 2.23 2.31 2.91 2.90 2.64 2.54 2.48 2.25 2.45 2.32 2.44 2.53 2.84 2.68 3.58 3.42 3.23 3.229
Interest Coverage 17.48 16.76 15.82 13.82 11.79 8.48 6.78 5.92 5.30 5.27 5.23 5.14 5.42 5.61 5.63 5.94 6.13 5.89 5.88 5.83 5.830
Equity Multiplier 2.33 2.26 2.14 2.08 2.21 2.24 2.15 2.14 2.11 2.13 2.08 2.05 1.96 2.01 2.00 2.02 2.07 2.18 2.15 2.09 2.086
Cash Ratio snapshot only 0.428
Debt Service Coverage snapshot only 7.114
Cash to Debt snapshot only 0.147
FCF to Debt snapshot only 0.184
Defensive Interval snapshot only 533.5 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 0.48 0.52 0.54 0.54 0.47 0.47 0.47 0.46 0.44 0.44 0.44 0.43 0.44 0.44 0.43 0.43 0.43 0.43 0.43 0.44 0.436
Inventory Turnover 4.38 4.38 4.50 4.68 4.94 4.77 4.70 4.76 4.87 4.76 4.70 4.71 5.07 4.92 4.85 4.71 5.19 5.11 4.94 4.94 4.936
Receivables Turnover 5.72 6.12 6.48 6.68 5.58 5.54 5.52 5.41 5.25 5.36 5.31 5.10 4.81 4.83 4.81 5.10 4.41 4.75 4.76 5.11 5.109
Payables Turnover 7.89 8.95 9.90 10.41 8.44 9.72 10.62 10.64 8.35 9.61 10.26 9.98 8.57 9.10 9.45 9.42 8.05 8.57 8.84 18.86 18.862
DSO 64 60 56 55 65 66 66 67 70 68 69 72 76 76 76 72 83 77 77 71 71.4 days
DIO 83 83 81 78 74 77 78 77 75 77 78 77 72 74 75 77 70 71 74 74 74.0 days
DPO 46 41 37 35 43 38 34 34 44 38 36 37 43 40 39 39 45 43 41 19 19.4 days
Cash Conversion Cycle 101 102 101 98 96 105 109 110 101 107 111 113 105 110 112 110 108 106 109 126 126.0 days
Fixed Asset Turnover snapshot only 4.477
Operating Cycle snapshot only 145.4 days
Cash Velocity snapshot only 7.812
Capital Intensity snapshot only 2.412
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 21.7% 14.6% 11.9% 13.1% 14.5% 6.5% 1.6% -1.7% -4.6% -3.0% -2.7% -2.4% 0.1% 1.0% 2.0% 3.2% 3.9% 5.4% 7.2% 8.3% 8.27%
Net Income 21.2% -4.1% -13.5% -17.9% -10.0% -20.8% -23.1% -15.5% -13.7% 0.2% 8.7% 3.3% 5.7% 8.0% 5.8% 7.1% 6.0% 5.3% 6.0% 7.8% 7.81%
EPS 21.8% -3.6% -13.0% -17.5% -8.9% -19.3% -21.9% -14.0% -12.6% 1.2% 10.2% 4.4% 7.1% 9.4% 7.2% 8.8% 7.7% 7.0% 8.0% 9.8% 9.84%
FCF 3.0% -10.3% -19.2% -26.3% -1.6% -22.3% -10.9% 12.3% 0.2% 34.5% 36.0% 18.8% 4.9% -11.1% -22.5% -21.4% -13.4% 0.4% 18.6% 24.3% 24.30%
EBITDA 18.4% -0.6% -6.7% -8.9% -0.2% -8.9% -11.9% -6.1% -6.5% 4.6% 10.9% 5.9% 5.1% 1.3% -3.4% -3.1% -2.2% -3.6% -1.2% -3.5% -3.51%
Op. Income 30.7% 0.7% -9.6% -14.7% -17.7% -27.0% -26.3% -19.3% -12.6% 1.1% 3.0% -0.8% 2.8% 4.2% 6.7% 7.9% 4.4% 3.1% 3.2% 6.9% 6.86%
OCF Growth snapshot only 21.87%
Asset Growth snapshot only 10.88%
Equity Growth snapshot only 7.34%
Debt Growth snapshot only 15.95%
Shares Change snapshot only -1.85%
Dividend Growth snapshot only 10.06%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y 17.2% 18.6% 19.9% 20.5% 20.7% 19.5% 18.4% 15.1% 10.0% 5.8% 3.4% 2.7% 3.0% 1.4% 0.3% -0.3% -0.3% 1.0% 2.1% 2.9% 2.93%
Revenue 5Y 16.5% 17.0% 17.4% 17.4% 16.5% 14.8% 13.5% 12.7% 12.0% 11.5% 11.2% 10.9% 10.9% 10.8% 10.5% 8.9% 6.7% 4.7% 3.9% 3.9% 3.93%
EPS 3Y 38.8% 34.7% 28.8% 26.0% 24.4% 19.2% 16.6% 7.8% -1.0% -7.7% -9.2% -9.5% -5.2% -3.7% -2.7% -0.8% 0.2% 5.8% 8.5% 7.6% 7.63%
EPS 5Y 30.7% 28.4% 26.8% 25.0% 26.3% 22.8% 19.9% 19.1% 16.3% 14.8% 12.9% 12.4% 12.5% 13.4% 13.3% 7.3% 2.2% -1.6% -2.8% -2.4% -2.42%
Net Income 3Y 38.0% 33.8% 28.1% 25.1% 23.4% 18.0% 15.6% 6.8% -2.0% -8.7% -10.2% -10.5% -6.4% -5.0% -4.0% -2.2% -1.1% 4.4% 6.8% 6.0% 6.04%
Net Income 5Y 30.7% 28.5% 26.8% 24.8% 25.6% 21.7% 19.0% 18.3% 15.3% 13.7% 11.9% 11.3% 11.4% 12.2% 12.2% 6.1% 1.0% -2.8% -4.1% -3.7% -3.73%
EBITDA 3Y 24.5% 23.4% 20.0% 18.8% 19.4% 16.1% 16.0% 10.3% 3.4% -1.8% -3.0% -3.2% -0.6% -1.2% -1.9% -1.2% -1.3% 0.7% 1.9% -0.3% -0.32%
EBITDA 5Y 22.3% 21.9% 21.4% 19.9% 18.8% 15.5% 13.6% 12.9% 12.5% 12.4% 11.1% 10.8% 10.8% 10.6% 10.9% 6.6% 2.6% -1.6% -2.7% -3.3% -3.25%
Gross Profit 3Y 22.3% 22.4% 22.1% 20.9% 18.9% 15.9% 13.4% 8.7% 2.1% -2.7% -4.5% -5.0% -3.5% -3.9% -4.5% -3.4% -1.8% 1.1% 3.4% 4.3% 4.34%
Gross Profit 5Y 17.3% 17.2% 17.0% 16.0% 14.9% 12.4% 10.9% 10.4% 9.6% 9.4% 9.3% 9.0% 9.5% 9.5% 8.0% 5.7% 2.2% -0.4% -0.7% -0.4% -0.44%
Op. Income 3Y 38.8% 36.6% 34.1% 30.2% 26.0% 20.1% 15.8% 7.1% -2.0% -9.4% -11.8% -11.9% -9.5% -8.4% -6.8% -4.7% -2.1% 2.8% 4.3% 4.6% 4.58%
Op. Income 5Y 30.9% 28.5% 26.5% 24.3% 21.2% 16.8% 15.1% 15.0% 14.0% 13.4% 12.8% 12.1% 12.5% 12.8% 11.3% 5.6% 0.2% -4.4% -5.5% -4.7% -4.66%
FCF 3Y 22.9% 19.2% 17.1% 14.0% 19.5% 14.9% 11.3% 4.8% 0.5% -2.1% -0.7% -0.6% 1.2% -2.4% -2.1% 1.6% -3.1% 6.3% 7.7% 5.1% 5.08%
FCF 5Y 21.0% 20.8% 18.7% 14.8% 14.6% 12.0% 9.7% 10.8% 12.8% 12.1% 14.3% 14.6% 12.4% 12.7% 7.8% 1.5% -1.6% -3.5% -2.1% -0.8% -0.82%
OCF 3Y 28.1% 24.1% 22.2% 19.8% 22.6% 18.0% 13.4% 6.0% 0.5% -3.4% -3.0% -3.7% -3.2% -5.9% -5.8% -2.9% -5.1% 2.6% 5.4% 4.5% 4.50%
OCF 5Y 24.8% 24.8% 23.3% 20.1% 18.0% 15.6% 12.2% 12.1% 13.1% 11.8% 13.5% 13.4% 11.8% 11.7% 7.5% 2.2% -1.2% -3.5% -2.5% -1.8% -1.77%
Assets 3Y 19.2% 18.6% 16.0% 16.9% 18.5% 17.3% 15.2% 14.9% 12.7% 13.8% 13.3% 10.9% 0.8% 2.2% 3.8% 4.4% 4.3% 6.2% 6.3% 5.6% 5.58%
Assets 5Y 15.7% 14.9% 14.3% 10.1% 11.4% 10.8% 11.2% 12.0% 11.9% 11.8% 11.2% 12.1% 10.8% 11.0% 10.4% 10.0% 9.8% 11.4% 10.8% 9.2% 9.19%
Equity 3Y 13.9% 13.9% 13.8% 14.1% 14.0% 14.0% 13.6% 12.5% 10.6% 9.1% 8.8% 8.2% 6.7% 6.4% 6.1% 5.4% 6.7% 7.1% 6.4% 6.5% 6.51%
Book Value 3Y 14.6% 14.7% 14.4% 14.9% 14.9% 15.1% 14.5% 13.6% 11.8% 10.3% 10.0% 9.4% 8.1% 7.9% 7.6% 7.0% 8.2% 8.5% 8.0% 8.1% 8.11%
Dividend 3Y 6.1% 6.4% 5.9% 6.0% 5.6% 5.6% 5.5% 5.5% 5.8% 6.0% 5.6% 5.3% 5.0% 4.8% 4.6% 4.5% 4.4% 4.2% 4.3% 4.2% 4.15%
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 0.93 0.91 0.89 0.92 0.95 0.93 0.89 0.90 0.92 0.88 0.80 0.75 0.74 0.71 0.66 0.62 0.62 0.74 0.82 0.84 0.844
Earnings Stability 0.90 0.83 0.79 0.83 0.88 0.65 0.53 0.56 0.56 0.33 0.24 0.20 0.20 0.06 0.03 0.00 0.09 0.33 0.29 0.24 0.238
Margin Stability 0.94 0.93 0.94 0.94 0.92 0.90 0.91 0.91 0.90 0.89 0.89 0.90 0.91 0.92 0.92 0.92 0.90 0.88 0.88 0.89 0.887
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.92 0.98 0.95 0.93 0.96 0.92 0.91 0.94 0.95 1.00 0.97 0.99 0.98 0.97 0.98 0.97 0.98 0.98 0.98 0.97 0.969
Earnings Smoothness 0.81 0.96 0.86 0.80 0.89 0.77 0.74 0.83 0.85 1.00 0.92 0.97 0.94 0.92 0.94 0.93 0.94 0.95 0.94 0.92 0.925
ROE Trend 0.03 0.01 -0.00 -0.03 -0.03 -0.06 -0.07 -0.06 -0.05 -0.03 -0.02 -0.02 -0.02 -0.01 -0.00 0.00 -0.00 -0.00 0.00 0.00 0.002
Gross Margin Trend 0.03 0.01 -0.02 -0.05 -0.08 -0.10 -0.09 -0.08 -0.06 -0.04 -0.03 -0.02 0.00 0.01 0.00 0.00 -0.00 -0.01 0.01 0.01 0.008
FCF Margin Trend -0.01 -0.01 -0.03 -0.07 -0.04 -0.07 -0.05 -0.02 -0.00 0.03 0.04 0.04 0.01 0.00 -0.02 -0.03 -0.02 -0.02 -0.01 -0.00 -0.001
Sustainable Growth Rate 19.5% 18.9% 17.7% 16.0% 15.3% 13.4% 12.2% 12.2% 12.1% 12.5% 12.4% 11.8% 11.9% 12.5% 12.2% 11.9% 11.8% 12.3% 12.2% 12.1% 12.12%
Internal Growth Rate 9.8% 10.0% 9.7% 8.7% 7.2% 6.3% 6.0% 6.2% 5.9% 6.1% 6.3% 6.0% 6.2% 6.4% 6.4% 6.2% 6.2% 6.2% 6.3% 6.3% 6.27%
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income 1.24 1.28 1.22 1.19 1.32 1.28 1.34 1.38 1.40 1.48 1.50 1.48 1.37 1.25 1.15 1.16 1.16 1.21 1.29 1.32 1.316
FCF/OCF 0.74 0.74 0.72 0.70 0.75 0.73 0.76 0.80 0.82 0.85 0.85 0.85 0.84 0.83 0.81 0.80 0.80 0.81 0.81 0.81 0.815
FCF/Net Income snapshot only 1.072
OCF/EBITDA snapshot only 0.853
CapEx/Revenue 6.4% 6.2% 5.8% 5.7% 5.0% 4.7% 4.2% 3.7% 3.5% 3.2% 3.3% 3.1% 3.3% 3.3% 3.3% 3.5% 3.4% 3.4% 3.7% 3.6% 3.65%
CapEx/Depreciation snapshot only 0.875
Accruals Ratio -0.02 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.03 -0.03 -0.03 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.021
Sloan Accruals snapshot only 0.019
Cash Flow Adequacy snapshot only 3.883
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.3% 0.3% 0.2% 0.3% 0.2% 0.3% 0.3% 0.4% 0.4% 0.3% 0.4% 0.3% 0.3% 0.26%
Dividend/Share $0.99 $1.04 $1.08 $1.12 $1.16 $1.21 $1.26 $1.30 $1.35 $1.41 $1.45 $1.48 $1.52 $1.58 $1.61 $1.65 $1.69 $1.74 $1.78 $1.81 $1.84
Payout Ratio 5.1% 5.4% 5.7% 6.3% 6.5% 7.8% 8.5% 8.5% 8.7% 9.0% 8.9% 9.3% 9.2% 9.2% 9.3% 9.5% 9.5% 9.5% 9.5% 9.5% 9.50%
FCF Payout Ratio 5.6% 5.7% 6.5% 7.6% 6.6% 8.3% 8.3% 7.7% 7.6% 7.2% 7.0% 7.3% 8.0% 8.9% 9.9% 10.2% 10.1% 9.6% 9.0% 8.9% 8.86%
Total Payout Ratio 32.3% 33.0% 34.0% 36.2% 49.8% 74.3% 78.5% 75.8% 58.8% 58.7% 57.1% 58.2% 72.3% 55.2% 54.8% 24.7% 54.1% 67.8% 81.1% 1.1% 1.08%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.17 0.18 0.17 0.17 0.15 0.14 0.15 0.15 0.15 0.16 0.14 0.13 0.12 0.11 0.10 0.10 0.09 0.09 0.09 0.08 0.083
Buyback Yield 0.8% 0.9% 1.0% 1.1% 1.4% 1.8% 2.0% 2.1% 1.5% 1.4% 1.4% 1.3% 2.0% 1.6% 1.9% 0.6% 1.4% 2.3% 2.6% 2.8% 2.80%
Net Buyback Yield 0.7% 0.8% 0.9% 1.0% 1.4% 1.8% 2.0% 2.1% 1.5% 1.4% 1.4% 1.3% 2.0% 1.6% 1.9% 0.6% 1.4% 2.3% 2.6% 2.8% 2.80%
Total Shareholder Return 0.9% 1.0% 1.1% 1.2% 1.6% 2.0% 2.2% 2.3% 1.7% 1.6% 1.7% 1.5% 2.3% 1.9% 2.3% 0.9% 1.7% 2.6% 3.0% 3.1% 3.06%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 0.87 0.88 0.88 0.90 0.91 0.93 0.95 0.95 0.96 0.93 0.92 0.91 0.91 0.93 0.94 0.92 0.92 0.93 0.92 0.90 0.900
Interest Burden (EBT/EBIT) 0.94 0.94 0.93 0.91 0.90 0.86 0.83 0.82 0.80 0.81 0.80 0.80 0.81 0.81 0.82 0.83 0.84 0.85 0.88 0.88 0.878
EBIT Margin 0.24 0.22 0.21 0.19 0.19 0.17 0.17 0.18 0.18 0.19 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.19 0.19 0.19 0.189
Asset Turnover 0.48 0.52 0.54 0.54 0.47 0.47 0.47 0.46 0.44 0.44 0.44 0.43 0.44 0.44 0.43 0.43 0.43 0.43 0.43 0.44 0.436
Equity Multiplier 2.18 2.09 2.00 2.00 2.27 2.25 2.15 2.11 2.16 2.18 2.11 2.09 2.04 2.07 2.04 2.03 2.02 2.10 2.08 2.05 2.054
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $19.41 $19.25 $18.88 $17.80 $17.68 $15.53 $14.74 $15.31 $15.45 $15.71 $16.24 $15.98 $16.54 $17.19 $17.42 $17.38 $17.81 $18.39 $18.81 $19.09 $19.09
Book Value/Share $102.49 $103.69 $107.34 $110.25 $111.90 $108.91 $112.76 $116.82 $120.45 $118.53 $123.84 $127.58 $129.46 $130.32 $133.63 $134.98 $141.66 $139.23 $141.99 $147.62 $148.02
Tangible Book/Share $-53.46 $-50.99 $-44.04 $-37.35 $-37.39 $-48.60 $-43.71 $-39.55 $-35.97 $-37.43 $-31.15 $-36.45 $-30.81 $-32.79 $-31.44 $-38.37 $-31.28 $-60.05 $-55.95 $-47.37 $-47.37
Revenue/Share $98.52 $104.11 $108.68 $111.82 $114.29 $112.90 $112.18 $111.91 $110.46 $110.66 $110.56 $110.34 $111.96 $113.19 $114.32 $115.70 $118.19 $121.17 $124.89 $127.63 $127.98
FCF/Share $17.64 $18.31 $16.67 $14.76 $17.59 $14.48 $15.09 $16.87 $17.85 $19.69 $20.79 $20.25 $18.97 $17.74 $16.32 $16.17 $16.69 $18.09 $19.73 $20.47 $20.53
OCF/Share $23.98 $24.73 $23.02 $21.15 $23.29 $19.80 $19.83 $21.06 $21.66 $23.25 $24.41 $23.70 $22.63 $21.47 $20.05 $20.24 $20.74 $22.22 $24.29 $25.13 $25.20
Cash/Share $11.25 $6.97 $4.79 $7.39 $21.69 $8.97 $8.07 $15.85 $20.83 $18.90 $23.07 $17.30 $14.54 $15.69 $16.91 $9.38 $26.82 $8.73 $10.95 $16.34 $16.38
EBITDA/Share $30.06 $30.38 $30.64 $29.76 $30.39 $28.17 $27.42 $28.45 $28.78 $29.77 $30.80 $30.45 $30.65 $30.55 $30.16 $29.98 $30.45 $29.92 $30.37 $29.47 $29.47
Debt/Share $91.30 $84.19 $76.80 $73.82 $91.79 $90.87 $87.65 $90.94 $93.88 $92.73 $92.44 $91.96 $85.57 $90.21 $93.20 $94.39 $108.37 $115.71 $114.69 $111.51 $111.51
Net Debt/Share $80.06 $77.22 $72.01 $66.43 $70.10 $81.89 $79.57 $75.09 $73.04 $73.83 $69.38 $74.66 $71.03 $74.52 $76.29 $85.01 $81.55 $106.98 $103.73 $95.17 $95.17
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.320
Altman Z-Prime snapshot only 5.606
Piotroski F-Score 6 4 4 5 6 5 4 5 7 7 8 7 8 8 8 8 5 4 7 8 8
Beneish M-Score -2.02 -2.05 -1.99 -1.94 -2.40 -2.42 -2.48 -2.48 -2.55 -2.65 -2.67 -2.61 -2.64 -2.49 -2.36 -2.61 -2.41 -2.34 -2.59 -2.43 -2.433
Ohlson O-Score snapshot only -9.099
Net-Net WC snapshot only $-91.24
EVA snapshot only $-1295513966.20
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only BBB+
Credit Score 77.92 82.82 82.82 82.14 76.95 71.73 70.62 72.32 72.71 76.58 77.29 76.44 79.18 73.84 69.72 71.24 73.56 68.59 69.74 62.94 62.945
Credit Grade snapshot only 8
Credit Trend snapshot only -8.294
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 40
Sector Credit Rank snapshot only 53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms